Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-312025-05-192025-05-19false2024-01-01Oliver Healthcare Packaging Companysale of healthcare packaging products32truetruefalse 14565745 2024-01-01 2024-12-31 14565745 2023-01-01 2023-12-31 14565745 2024-12-31 14565745 2023-12-31 14565745 c:Director1 2024-01-01 2024-12-31 14565745 c:Director2 2024-01-01 2024-12-31 14565745 d:CurrentFinancialInstruments 2024-12-31 14565745 d:CurrentFinancialInstruments 2023-12-31 14565745 d:Non-currentFinancialInstruments 2024-12-31 14565745 d:Non-currentFinancialInstruments 2023-12-31 14565745 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 14565745 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 14565745 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 14565745 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 14565745 d:ShareCapital 2024-12-31 14565745 d:ShareCapital 2023-12-31 14565745 d:RetainedEarningsAccumulatedLosses 2024-12-31 14565745 d:RetainedEarningsAccumulatedLosses 2023-12-31 14565745 c:FRS102 2024-01-01 2024-12-31 14565745 c:Audited 2024-01-01 2024-12-31 14565745 c:FullAccounts 2024-01-01 2024-12-31 14565745 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 14565745 c:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 14565745 2 2024-01-01 2024-12-31 14565745 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 14565745










OLIVER HEALTHCARE PACKAGING UK LIMITED










FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
OLIVER HEALTHCARE PACKAGING UK LIMITED
REGISTERED NUMBER: 14565745

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
775,646
1,017,565

Cash at bank and in hand
 5 
90,653
-

  
866,299
1,017,565

Creditors: amounts falling due within one year
 6 
(691,139)
(742,774)

Net current assets
  
 
 
175,160
 
 
274,791

Total assets less current liabilities
  
175,160
274,791

Creditors: amounts falling due after more than one year
 7 
(5,675)
(172,382)

  

Net assets
  
169,485
102,409


Capital and reserves
  

Called up share capital 
  
1,000
1,000

Profit and loss account
  
168,485
101,409

  
169,485
102,409


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 19 May 2025.




Michael James Benevento
Douglas Allen Kramer
Director
Director

The notes on pages 2 to 5 form part of these financial statements.

Page 1

 
OLIVER HEALTHCARE PACKAGING UK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

The principle activity of the company during the year has been the sale of healthcare packaging products.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of Oliver Healthcare Packaging Company as at 31/12/2024 and these financial statements may be obtained from 445 6th St NW, Grand Rapids, MI 49504, United States..

 
2.3

Going concern

The directors have assessed the Company's ability to continue as a going concern and have a reasonable expectation that the company has adequite resource to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statments.

  
2.4

Revenue

Turnover is measured at the fair value of the consideration received or receivable and represents the amount receivable for services rendered, net of returns, discounts and rebates allowed by the company.

The company earns commission from other manufacturers in relation to the sale of products designed by the company. Commission income is recognised on an accruals basis in accordance with the substance of the relevant agreement.

 
2.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 2

 
OLIVER HEALTHCARE PACKAGING UK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

In December 2021, the OECD issued model rules for a new global minimum tax framework (Pillar Two) applicable for multinational enterprise groups with global revenue over €750m. The legislation implementing the rules in the UK was substantively enacted on 20 June 2023 and first has effect for the Company for the year ended 31 December 2024. The Company has applied the exemption under FRS 102 in relation to accounting for deferred tax assets and liabilities arising from the implementation of the Pillar Two model rules.
There has been no change to the conclusions reached in the group’s assessment of the potential exposure to Pillar Two income taxes performed in 2023.  A current tax expense has not been recorded in respect of Pillar Two income taxes in this Company for the year ending 31 December 2024 due to the transitional safe harbor rules applying and the effective tax rate is above 15% in the UK jurisdiction.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 3

 
OLIVER HEALTHCARE PACKAGING UK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 3 (2023 - 2).


4.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
763,409
1,017,565

Other debtors
10,367
-

Deferred taxation
1,870
-

775,646
1,017,565


Amounts owed by group undertakings are unsecured, interest free and repayable on demand.


5.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
90,653
-

90,653
-


Page 4

 
OLIVER HEALTHCARE PACKAGING UK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Amounts owed to group undertakings
481,189
467,281

Corporation tax
-
31,187

Other taxation and social security
16,972
-

Other creditors
17,346
-

Accruals and deferred income
175,632
244,306

691,139
742,774


Amounts owed to group undertakings are unsecured, interest free and repayable on demand.


7.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Accruals and deferred income
5,675
172,382

5,675
172,382



8.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £30,188 (2023 - £23,426). All contributions have been fully paid as at the balance sheet date, and their are no outstanding liabilities. 


9.


Controlling party

The immediate parent undertaking and controlling party is Oliver Healthcare Packaging Company, a company incorporated in the USA. There is no one ultimate controlling party due to the the Group Structure.


10.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2024 was unqualified.

The audit report was signed on 19 May 2025 by Teresa Campbell (Senior statutory auditor) on behalf of AAB Group Accountants Limited.

Page 5